P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P17706 |
PTN2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P17706 |
PTN2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P17706 |
PTN2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P23219 |
PGH1_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P23219 |
PGH1_HUMAN |
Endometriosis [ICD-11: GA10] |
P23219 |
PGH1_HUMAN |
Eye anterior segment structural developmental anomaly [ICD-11: LA11] |
P23219 |
PGH1_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P23219 |
PGH1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P23219 |
PGH1_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P23219 |
PGH1_HUMAN |
Nutritional deficiency [ICD-11: 5B50-5B71] |
P23219 |
PGH1_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P23219 |
PGH1_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P23219 |
PGH1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P23219 |
PGH1_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P23219 |
PGH1_HUMAN |
Seborrhoeic dermatitis [ICD-11: EA81] |
P23219 |
PGH1_HUMAN |
Tuberculosis [ICD-11: 1B10-1B12] |
P23219 |
PGH1_HUMAN |
Ulcerative colitis [ICD-11: DD71] |
P23219 |
PGH1_HUMAN |
Shoulder lesion [ICD-11: FB53] |
P23219 |
PGH1_HUMAN |
Soft tissue disorder [ICD-11: FB56] |
P23219 |
PGH1_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P23219 |
PGH1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P23219 |
PGH1_HUMAN |
Systemic sclerosis [ICD-11: 4A42] |
P23219 |
PGH1_HUMAN |
Vasculitis [ICD-11: 4A44] |
P23219 |
PGH1_HUMAN |
Ataxic disorder [ICD-11: 8A03] |
P23219 |
PGH1_HUMAN |
Muscular dystrophy [ICD-11: 8C70] |
P23219 |
PGH1_HUMAN |
Neuropathy [ICD-11: 8C0Z] |
P23219 |
PGH1_HUMAN |
Fever [ICD-11: MG26] |
P23219 |
PGH1_HUMAN |
Gout [ICD-11: FA25] |
P23219 |
PGH1_HUMAN |
Sensation disturbance [ICD-11: MB40] |
P23219 |
PGH1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P23219 |
PGH1_HUMAN |
General pain disorder [ICD-11: 8E43] |
O75874 |
IDHC_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 |
IDHC_HUMAN |
Liver cancer [ICD-11: 2C12] |
O75874 |
IDHC_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
O75874 |
IDHC_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O75874 |
IDHC_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 |
IDHC_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 |
APEX1_HUMAN |
Retinopathy [ICD-11: 9B71] |
P27695 |
APEX1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 |
APEX1_HUMAN |
Ocular cancer [ICD-11: 2D00-2D07] |
P27695 |
APEX1_HUMAN |
Brain cancer [ICD-11: 2A00] |
P27695 |
APEX1_HUMAN |
Melanoma [ICD-11: 2C30] |
P11511 |
CP19A_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P11511 |
CP19A_HUMAN |
Cushing syndrome [ICD-11: 5A70] |
P11511 |
CP19A_HUMAN |
Oesophagitis [ICD-11: DA24] |
P11511 |
CP19A_HUMAN |
Endometriosis [ICD-11: GA10] |
P11511 |
CP19A_HUMAN |
Neuropathy [ICD-11: 8C0Z] |
P11511 |
CP19A_HUMAN |
Bladder cancer [ICD-11: 2C94] |
P11511 |
CP19A_HUMAN |
Prostate disease [ICD-11: GA91] |
P11597 |
CETP_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P11597 |
CETP_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P11597 |
CETP_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P11597 |
CETP_HUMAN |
Myocardial infarction [ICD-11: BA41-BA43] |
P11597 |
CETP_HUMAN |
Inborn lipid metabolism error [ICD-11: 5C52] |
P11597 |
CETP_HUMAN |
Chronic arterial occlusive disease [ICD-11: BD4Z] |
P11597 |
CETP_HUMAN |
Dyslipidemia [ICD-11: 5C80-5C81] |
P08246 |
ELNE_HUMAN |
Intrathoracic organs injury [ICD-11: NB32] |
P08246 |
ELNE_HUMAN |
Pneumonia [ICD-11: CA40] |
P08246 |
ELNE_HUMAN |
Anterior uveitis [ICD-11: 9A96] |
P08246 |
ELNE_HUMAN |
Crohn disease [ICD-11: DD70] |
P08246 |
ELNE_HUMAN |
Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
P08246 |
ELNE_HUMAN |
Inflammatory spondyloarthritis [ICD-11: FA92] |
P08246 |
ELNE_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P08246 |
ELNE_HUMAN |
Psoriatic arthritis [ICD-11: FA21] |
P08246 |
ELNE_HUMAN |
Pyoderma gangrenosum [ICD-11: EB21] |
P08246 |
ELNE_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P08246 |
ELNE_HUMAN |
Ulcerative colitis [ICD-11: DD71] |
P08246 |
ELNE_HUMAN |
Bronchiectasis [ICD-11: CA24] |
P08246 |
ELNE_HUMAN |
Chronic obstructive pulmonary disease [ICD-11: CA22] |
P08246 |
ELNE_HUMAN |
Cystic fibrosis [ICD-11: CA25] |
P08246 |
ELNE_HUMAN |
Myocardial infarction [ICD-11: BA41-BA43] |
P08246 |
ELNE_HUMAN |
Phlegmy cough [ICD-11: SA80-SA8Z] |
P08246 |
ELNE_HUMAN |
Atopic eczema [ICD-11: EA80] |
P08246 |
ELNE_HUMAN |
Emphysema [ICD-11: CA21] |
P08246 |
ELNE_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P08246 |
ELNE_HUMAN |
Acute respiratory distress syndrome [ICD-11: CB00] |
P08246 |
ELNE_HUMAN |
Injury [ICD-11: NA00-ND5Z] |
P08246 |
ELNE_HUMAN |
Pulmonary disease [ICD-11: 1B10-1F85] |
P08246 |
ELNE_HUMAN |
Sepsis [ICD-11: 1G40-1G41] |
P35354 |
PGH2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P35354 |
PGH2_HUMAN |
Chronic pain [ICD-11: MG30] |
P35354 |
PGH2_HUMAN |
Endometriosis [ICD-11: GA10] |
P35354 |
PGH2_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P35354 |
PGH2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P35354 |
PGH2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P35354 |
PGH2_HUMAN |
Knee osteoarthritis [ICD-11: FA01] |
P35354 |
PGH2_HUMAN |
Migraine [ICD-11: 8A80] |
P35354 |
PGH2_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P35354 |
PGH2_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P35354 |
PGH2_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P35354 |
PGH2_HUMAN |
Tuberculosis [ICD-11: 1B10-1B12] |
P35354 |
PGH2_HUMAN |
Shoulder lesion [ICD-11: FB53] |
P35354 |
PGH2_HUMAN |
Soft tissue disorder [ICD-11: FB56] |
P35354 |
PGH2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P35354 |
PGH2_HUMAN |
Asthma [ICD-11: CA23] |
P35354 |
PGH2_HUMAN |
Gout [ICD-11: FA25] |
P35354 |
PGH2_HUMAN |
General pain disorder [ICD-11: 8E43] |
P35354 |
PGH2_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P35354 |
PGH2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P35354 |
PGH2_HUMAN |
Large intestine polyp [ICD-11: DB35] |
P35354 |
PGH2_HUMAN |
Lung cancer [ICD-11: 2C25] |
P35354 |
PGH2_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P35354 |
PGH2_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P35354 |
PGH2_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P35354 |
PGH2_HUMAN |
Fever [ICD-11: MG26] |
P35354 |
PGH2_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P35354 |
PGH2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P35354 |
PGH2_HUMAN |
Chronic pain [ICD-11: MG30] |
P35354 |
PGH2_HUMAN |
Endometriosis [ICD-11: GA10] |
P35354 |
PGH2_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P35354 |
PGH2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P35354 |
PGH2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P35354 |
PGH2_HUMAN |
Knee osteoarthritis [ICD-11: FA01] |
P35354 |
PGH2_HUMAN |
Migraine [ICD-11: 8A80] |
P35354 |
PGH2_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P35354 |
PGH2_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P35354 |
PGH2_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P35354 |
PGH2_HUMAN |
Tuberculosis [ICD-11: 1B10-1B12] |
P35354 |
PGH2_HUMAN |
Shoulder lesion [ICD-11: FB53] |
P35354 |
PGH2_HUMAN |
Soft tissue disorder [ICD-11: FB56] |
P35354 |
PGH2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P35354 |
PGH2_HUMAN |
Asthma [ICD-11: CA23] |
P35354 |
PGH2_HUMAN |
Gout [ICD-11: FA25] |
P35354 |
PGH2_HUMAN |
General pain disorder [ICD-11: 8E43] |
P35354 |
PGH2_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P35354 |
PGH2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P35354 |
PGH2_HUMAN |
Large intestine polyp [ICD-11: DB35] |
P35354 |
PGH2_HUMAN |
Lung cancer [ICD-11: 2C25] |
P35354 |
PGH2_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P35354 |
PGH2_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P35354 |
PGH2_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P35354 |
PGH2_HUMAN |
Fever [ICD-11: MG26] |
P35354 |
PGH2_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P35354 |
PGH2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P35354 |
PGH2_HUMAN |
Chronic pain [ICD-11: MG30] |
P35354 |
PGH2_HUMAN |
Endometriosis [ICD-11: GA10] |
P35354 |
PGH2_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P35354 |
PGH2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P35354 |
PGH2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P35354 |
PGH2_HUMAN |
Knee osteoarthritis [ICD-11: FA01] |
P35354 |
PGH2_HUMAN |
Migraine [ICD-11: 8A80] |
P35354 |
PGH2_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P35354 |
PGH2_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P35354 |
PGH2_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P35354 |
PGH2_HUMAN |
Tuberculosis [ICD-11: 1B10-1B12] |
P35354 |
PGH2_HUMAN |
Shoulder lesion [ICD-11: FB53] |
P35354 |
PGH2_HUMAN |
Soft tissue disorder [ICD-11: FB56] |
P35354 |
PGH2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P35354 |
PGH2_HUMAN |
Asthma [ICD-11: CA23] |
P35354 |
PGH2_HUMAN |
Gout [ICD-11: FA25] |
P35354 |
PGH2_HUMAN |
General pain disorder [ICD-11: 8E43] |
P35354 |
PGH2_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P35354 |
PGH2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P35354 |
PGH2_HUMAN |
Large intestine polyp [ICD-11: DB35] |
P35354 |
PGH2_HUMAN |
Lung cancer [ICD-11: 2C25] |
P35354 |
PGH2_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P35354 |
PGH2_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P35354 |
PGH2_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P35354 |
PGH2_HUMAN |
Fever [ICD-11: MG26] |
P35354 |
PGH2_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P06746 |
DPOLB_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q16665 |
HIF1A_HUMAN |
Adrenomedullary hyperfunction [ICD-11: 5A75] |
Q16665 |
HIF1A_HUMAN |
Brain cancer [ICD-11: 2A00] |
Q16665 |
HIF1A_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
Q16665 |
HIF1A_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q16665 |
HIF1A_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
Q16665 |
HIF1A_HUMAN |
Adrenomedullary hyperfunction [ICD-11: 5A75] |
Q16665 |
HIF1A_HUMAN |
Brain cancer [ICD-11: 2A00] |
Q16665 |
HIF1A_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
Q16665 |
HIF1A_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q16665 |
HIF1A_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
P28845 |
DHI1_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
P28845 |
DHI1_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P28845 |
DHI1_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P28845 |
DHI1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P28845 |
DHI1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P28845 |
DHI1_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P28845 |
DHI1_HUMAN |
Glaucoma [ICD-11: 9C61] |
P28845 |
DHI1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P28845 |
DHI1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P28845 |
DHI1_HUMAN |
Inborn lipid metabolism error [ICD-11: 5C52] |
P28845 |
DHI1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P51449 |
RORG_HUMAN |
Autoimmune disease [ICD-11: 4A40-4A45] |
P51449 |
RORG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P51449 |
RORG_HUMAN |
Psoriasis [ICD-11: EA90] |
P51449 |
RORG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P51449 |
RORG_HUMAN |
Crohn disease [ICD-11: DD70] |
P51449 |
RORG_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P51449 |
RORG_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P51449 |
RORG_HUMAN |
Liver cancer [ICD-11: 2C12] |
P51449 |
RORG_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P15121 |
ALDR_HUMAN |
Neuropathy [ICD-11: 8C0Z] |
P15121 |
ALDR_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P15121 |
ALDR_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P15121 |
ALDR_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P15121 |
ALDR_HUMAN |
Thrombosis [ICD-11: DB61-GB90] |
P15121 |
ALDR_HUMAN |
Cataract [ICD-11: 9B10] |
P15121 |
ALDR_HUMAN |
Glaucoma [ICD-11: 9C61] |
P15121 |
ALDR_HUMAN |
Schizophrenia [ICD-11: 6A20] |
P15121 |
ALDR_HUMAN |
Gout [ICD-11: FA25] |
P15121 |
ALDR_HUMAN |
Head and neck cancer [ICD-11: 2D42] |
Q96RI1 |
NR1H4_HUMAN |
Autoimmune liver disease [ICD-11: DB96] |
Q96RI1 |
NR1H4_HUMAN |
Cholelithiasis [ICD-11: DC11] |
Q96RI1 |
NR1H4_HUMAN |
Insomnia [ICD-11: 7A00-7A0Z] |
Q96RI1 |
NR1H4_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
Q96RI1 |
NR1H4_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q96RI1 |
NR1H4_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q96RI1 |
NR1H4_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
Q96RI1 |
NR1H4_HUMAN |
Skeletal anomaly [ICD-11: LD24] |
Q96RI1 |
NR1H4_HUMAN |
Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
Q96RI1 |
NR1H4_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q96RI1 |
NR1H4_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
Q07869 |
PPARA_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
Q07869 |
PPARA_HUMAN |
Hyperlipidemia [ICD-11: 5C80] |
Q07869 |
PPARA_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q07869 |
PPARA_HUMAN |
Inborn lipid metabolism error [ICD-11: 5C52] |
Q07869 |
PPARA_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
Q07869 |
PPARA_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
Q07869 |
PPARA_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q07869 |
PPARA_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
Q07869 |
PPARA_HUMAN |
Dyslipidemia [ICD-11: 5C80-5C81] |
Q07869 |
PPARA_HUMAN |
Gout [ICD-11: FA25] |
Q07869 |
PPARA_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q07869 |
PPARA_HUMAN |
Heart failure [ICD-11: BD10-BD1Z] |
Q07869 |
PPARA_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
Q07869 |
PPARA_HUMAN |
Idiopathic interstitial pneumonitis [ICD-11: CB03] |
Q07869 |
PPARA_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
Q07869 |
PPARA_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
Q93009 |
UBP7_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q93009 |
UBP7_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P09917 |
LOX5_HUMAN |
Asthma [ICD-11: CA23] |
P09917 |
LOX5_HUMAN |
Filariasis [ICD-11: 1F66] |
P09917 |
LOX5_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
P09917 |
LOX5_HUMAN |
Lung cancer [ICD-11: 2C25] |
P09917 |
LOX5_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P09917 |
LOX5_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P09917 |
LOX5_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P09917 |
LOX5_HUMAN |
Atopic eczema [ICD-11: EA80] |
P09917 |
LOX5_HUMAN |
Carcinoid syndrome [ICD-11: 5B10] |
P09917 |
LOX5_HUMAN |
Fungal infection [ICD-11: 1F29-1F2F] |
P09917 |
LOX5_HUMAN |
Idiopathic interstitial pneumonitis [ICD-11: CB03] |
P09917 |
LOX5_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
P09917 |
LOX5_HUMAN |
Pituitary gland disorder [ICD-11: 5A60-5A61] |
P09917 |
LOX5_HUMAN |
Psoriasis [ICD-11: EA90] |
P09917 |
LOX5_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P09917 |
LOX5_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P09917 |
LOX5_HUMAN |
Respiratory system disease [ICD-11: CB40-CB7Z] |
P09917 |
LOX5_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P09917 |
LOX5_HUMAN |
Chronic obstructive pulmonary disease [ICD-11: CA22] |
P09917 |
LOX5_HUMAN |
Eczema [ICD-11: EA80-EA89] |
P09917 |
LOX5_HUMAN |
Pruritus [ICD-11: EC90] |
P09917 |
LOX5_HUMAN |
Thrombosis [ICD-11: DB61-GB90] |
P09917 |
LOX5_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P09917 |
LOX5_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P09917 |
LOX5_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P09917 |
LOX5_HUMAN |
Malaria [ICD-11: 1F40-1F45] |
P09917 |
LOX5_HUMAN |
Asthma [ICD-11: CA23] |
P09917 |
LOX5_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P09917 |
LOX5_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P10253 |
LYAG_HUMAN |
Inborn carbohydrate metabolism error [ICD-11: 5C51] |
P10253 |
LYAG_HUMAN |
Inborn carbohydrate metabolism error [ICD-11: 5C51] |
Q8TDU6 |
GPBAR_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
Q8TDU6 |
GPBAR_HUMAN |
Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
Q8TDU6 |
GPBAR_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
Q96T53 |
MBOA4_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
Q96T53 |
MBOA4_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P07339 |
CATD_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P07339 |
CATD_HUMAN |
Hypertension [ICD-11: BA00-BA04] |
P07339 |
CATD_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P07339 |
CATD_HUMAN |
Hypertension [ICD-11: BA00-BA04] |
P03452 |
HEMA_I34A1 |
Virus infection [ICD-11: 1A24-1D9Z] |
P03452 |
HEMA_I34A1 |
Influenza [ICD-11: 1E30-1E32] |
P03452 |
HEMA_I34A1 |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q96KS0 |
EGLN2_HUMAN |
Acute disease anaemia [ICD-11: 3A90] |
Q96KS0 |
EGLN2_HUMAN |
Autism spectrum disorder [ICD-11: 6A02] |
Q96KS0 |
EGLN2_HUMAN |
Diabetic foot ulcer [ICD-11: BD54] |
Q96KS0 |
EGLN2_HUMAN |
Urinary system disease [ICD-11: GC2Z] |
Q96KS0 |
EGLN2_HUMAN |
Anemia [ICD-11: 3A00-3A9Z] |
Q9GZT9 |
EGLN1_HUMAN |
Acute disease anaemia [ICD-11: 3A90] |
Q9GZT9 |
EGLN1_HUMAN |
Urinary system disease [ICD-11: GC2Z] |
Q9GZT9 |
EGLN1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |